Laddar...
Taxane Chemotherapy for Hormone-Naïve Prostate Cancer with Its Expanding Role as Breakthrough Strategy
Historically, androgen-deprivation therapy (ADT) was the only primary treatment for metastatic prostate cancer. After prostate cancer develops into castration-resistant prostate cancer (CRPC), there are a few life-prolonging drugs, including taxanes, such as docetaxel and cabazitaxel, as well as nov...
Sparad:
| I publikationen: | Front Oncol |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4707543/ https://ncbi.nlm.nih.gov/pubmed/26793621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2015.00304 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|